Tenderwize
Retour à la recherche

Produits pharmaceutiques pour le projet rescEU Medical

Finnish Institute for Health and Welfare·Helsinki, Finland·Deadline Dec 09, 2026 · 21 days left·Open·Supplies
Titre original de l'avis

Finland – Pharmaceutical products – Various pharmaceutical products for rescEU Medical -project

0/100

Score d'opportunité

High riskLow complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

0 / 100

Complexité

0 / 100

Facteurs de risque

No procurement documents available

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
Finnish Institute for Health and Welfare
Pays
Finlande
CPV
33621400 - Blood substitutes and perfusion solutions +7 autres
Date limite
Dec 09, 2026

Analyse IA de l'appel d'offres

Tenderwize prépare une analyse IA de cet appel d'offres à partir de l'avis TED et des documents de consultation : périmètre, exigences clés, critères de sélection, risques et questions à poser à l'acheteur. L'analyse est générée à l'ouverture de l'appel d'offres.

Critères d'attribution

Lot 1

Reference price — 65%Quality 1: Registered shelf life of the Article — 15%Quality 2: Delivery time to the customer’s warehouse — 10%Quality 3: Transportation temperature and excursions — 3%Quality 4: Marketing authorisation valid in Finland and Finnish language of packaging — 7%

Lot 2

Reference price — 65%Quality 1: Registered shelf life of the Article — 15%Quality 2: Delivery time to the customer’s warehouse — 10%Quality 3: Transportation temperature and excursions — 3%Quality 4: Marketing authorisation valid in Finland and Finnish language of packaging — 7%

Lot 3

Reference price — 65%Quality 1: Registered shelf life of the Article — 15%Quality 2: Delivery time to the customer’s warehouse — 10%Quality 3: Transportation temperature and excursions — 3%Quality 4: Marketing authorisation valid in Finland and Finnish language of packaging — 7%

Lot 4

Reference price — 65%Quality 1: Registered shelf life of the Article — 15%Quality 2: Delivery time to the customer’s warehouse — 10%Quality 3: Transportation temperature and excursions — 3%Quality 4: Marketing authorisation valid in Finland and Finnish language of packaging — 7%

Lot 5

Reference price — 65%Quality 1: Registered shelf life of the Article — 15%Quality 2: Delivery time to the customer’s warehouse — 10%Quality 3: Transportation temperature and excursions — 3%Quality 4: Marketing authorisation valid in Finland and Finnish language of packaging — 7%

Lot 6

Reference price — 65%Quality 1: Registered shelf life of the Article — 15%Quality 2: Delivery time to the customer’s warehouse — 10%Quality 3: Transportation temperature and excursions — 3%Quality 4: Marketing authorisation valid in Finland and Finnish language of packaging — 7%

Lot 7

Reference price — 65%Quality 1: Registered shelf life of the Article — 15%Quality 2: Delivery time to the customer’s warehouse — 10%Quality 3: Transportation temperature and excursions — 3%Quality 4: Marketing authorisation valid in Finland and Finnish language of packaging — 7%

Lot 8

Reference price — 65%Quality 1: Registered shelf life of the Article — 15%Quality 2: Delivery time to the customer’s warehouse — 10%Quality 3: Transportation temperature and excursions — 3%Quality 4: Marketing authorisation valid in Finland and Finnish language of packaging — 7%

Lot 9

Reference price — 65%Quality 1: Registered shelf life of the Article — 15%Quality 2: Delivery time to the customer’s warehouse — 10%Quality 3: Transportation temperature and excursions — 3%Quality 4: Marketing authorisation valid in Finland and Finnish language of packaging — 7%

Lot 10

Reference price — 65%Quality 1: Registered shelf life of the Article — 15%Quality 2: Delivery time to the customer’s warehouse — 10%Quality 3: Transportation temperature and excursions — 3%Quality 4: Marketing authorisation valid in Finland and Finnish language of packaging — 7%

Acheteur

Localisation

Helsinki, FIN

Site web

www.thl.fi/

Identifiant

2229500-6

Activité

General public services

Lots (10)

LOT-0001

LOT 1: Electrolytes (ringer's solution) 1000 ml (intravenous infusion, ATC B05BB01)

The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Electrolytes (ringer's solution) 1000 ml (intravenous infusion, ATC B05BB01) - Active pharmaceutical ingredient: Electrolytes (ringer's solution) - Container size: 1000 ml - Pharmaceutical form: intravenous infusion - ATC code: B05BB01 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).

SuppliesEU fundedElectronic submissionSME suitable

Localisation

Finland

Durée

Jan 2027

Catégorie

Blood substitutes and perfusion solutions

Critères d'attribution

Best price-quality ratio

LOT-0002

LOT 2: Electrolytes with carbohydrates 50 mg/ml (500 ml, solution for infusion, ATC B05BB02)

The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Electrolytes with carbohydrates 50 mg/ml (500 ml, solution for infusion, ATC B05BB02) - Active pharmaceutical ingredient: Electrolytes with carbohydrates - Strength: 50 mg/ml - Container size: 500 ml - Pharmaceutical form: solution for infusion - ATC code: B05BB02 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).

SuppliesEU fundedElectronic submissionSME suitable

Localisation

Finland

Durée

Jan 2027

Catégorie

Blood substitutes and perfusion solutions

Critères d'attribution

Best price-quality ratio

LOT-0003

LOT 3: Esketamine 25 mg/ml (2 ml, solution for injection/infusion, ATC N01AX14)

The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Esketamine 25 mg/ml (2 ml, solution for injection/infusion, ATC N01AX14) - Active pharmaceutical ingredient: Esketamine - Strength: 25 mg/ml - Container size: 2 ml - Pharmaceutical form: solution for injection/infusion, vial/ampoule - ATC code: N01AX14 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).

SuppliesEU fundedElectronic submissionSME suitable

Localisation

Finland

Durée

Jan 2027

Catégorie

Anaesthetics

Critères d'attribution

Best price-quality ratio

LOT-0004

LOT 4: Oxycodone 10 mg/ml (1 ml, solution for injection, ATC N02AA05)

The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Oxycodone 10 mg/ml (1 ml, solution for injection, ATC N02AA05) - Active pharmaceutical ingredient: Oxycodone - Strength: 10 mg/ml - Container size: 1 ml - Pharmaceutical form: solution for injection, vial/ampoule - ATC code: N02AA05 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).

SuppliesEU fundedElectronic submissionSME suitable

Localisation

Finland

Durée

Jan 2027

Catégorie

Analgesics

Critères d'attribution

Best price-quality ratio

LOT-0005

LOT 5: Oxycodone 10 mg/ml (10 ml, solution for injection, ATC N02AA05)

The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Oxycodone 10 mg/ml (10 ml, solution for injection, ATC N02AA05) - Active pharmaceutical ingredient: Oxycodone - Strength: 10 mg/ml - Container size: 10 ml - Pharmaceutical form: solution for injection, vial/ampoule - ATC code: N02AA05 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).

SuppliesEU fundedElectronic submissionSME suitable

Localisation

Finland

Durée

Jan 2027

Catégorie

Analgesics

Critères d'attribution

Best price-quality ratio

LOT-0006

LOT 6: Levetiracetam 100 mg/ml (5 ml, concentrate for solution for infusion, ATC N03AX14)

The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Levetiracetam 100 mg/ml (5 ml, concentrate for solution for infusion, ATC N03AX14) - Active pharmaceutical ingredient: Levetiracetam - Strength: 100 mg/ml - Container size: 5 ml - Pharmaceutical form: concentrate for solution for infusion, vial - ATC code: N03AX14 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).

SuppliesEU fundedElectronic submissionSME suitable

Localisation

Finland

Durée

Jan 2027

Catégorie

Antiepileptics

Critères d'attribution

Best price-quality ratio

LOT-0007

LOT 7: Cefuroxime 1500 mg (powder for solution for injection, ATC J01DC02)

The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Cefuroxime 1500 mg (powder for solution for injection, ATC J01DC02) - Active pharmaceutical ingredient: Cefuroxime - Strength: 1500 mg - Pharmaceutical form: powder for solution for injection, vial - ATC code: J01DC02 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).

SuppliesEU fundedElectronic submissionSME suitable

Localisation

Finland

Durée

Jan 2027

Catégorie

Antibacterials for systemic use

Critères d'attribution

Best price-quality ratio

LOT-0008

LOT 8: Vancomycin 1000 mg (powder for solution for injection, ATC J01XA01)

The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Vancomycin 1000 mg (powder for solution for injection, ATC J01XA01) - Active pharmaceutical ingredient: Vancomycin - Strength: 1000 mg - Pharmaceutical form: powder for solution for injection, vial - ATC code: J01XA01 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).

SuppliesEU fundedElectronic submissionSME suitable

Localisation

Finland

Durée

Jan 2027

Catégorie

Antibacterials for systemic use

Critères d'attribution

Best price-quality ratio

LOT-0009

LOT 9: Enoxaparin 100 mg/ml (1 ml, sub-cutaneous, ATC B01AB05)

The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Enoxaparin 100 mg/ml (1 ml, sub-cutaneous, ATC B01AB05) - Active pharmaceutical ingredient: Enoxaparin - Strength: 100 mg/ml - Container size: 1 ml - Pharmaceutical form: sub-cutaneous, pre-filled syringe - ATC code: B01AB05 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).

SuppliesEU fundedElectronic submissionSME suitable

Localisation

Finland

Durée

Jan 2027

Catégorie

Antithrombotic agents

Critères d'attribution

Best price-quality ratio

LOT-0010

LOT 10: Tranexamic acid 100 mg/ml (10 ml, intra muscular/intravenous, ATC B02AA02)

The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Tranexamic acid 100 mg/ml (10 ml, intra muscular/intravenous, ATC B02AA02) - Active pharmaceutical ingredient: Tranexamic acid - Strength: 100 mg/ml - Container size: 10 ml - Pharmaceutical form: intra muscular/intravenous, vial/ampoule - ATC code: B02AA02 The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the Article is described in Annex 1. Quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 6, the Customer shall be entitled to purchase 100 % extra to the original quantities described in the Annex 6 (later referred as "Option"). The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Stock Keeping Unit (SKU).

SuppliesEU fundedElectronic submissionSME suitable

Localisation

Finland

Durée

Jan 2027

Catégorie

Antihaemorrhagics

Critères d'attribution

Best price-quality ratio

Détails de la procédure

Date de publication
15 Nov 2026
Langues
English

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
795969-2026

Documents (1)

Appels d'offres similaires

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy